John C. Burnett
John C. Burnett
Assistant Professor in the Center for Gene Therapy at the Beckman Research Institute of City of Hope
Verified email at coh.org - Homepage
Title
Cited by
Cited by
Year
RNA-based therapeutics: current progress and future prospects
JC Burnett, JJ Rossi
Chemistry & biology 19 (1), 60-71, 2012
8442012
Stochastic gene expression in a lentiviral positive-feedback loop: HIV-1 Tat fluctuations drive phenotypic diversity
LS Weinberger, JC Burnett, JE Toettcher, AP Arkin, DV Schaffer
Cell 122 (2), 169-182, 2005
5782005
Current progress of siRNA/shRNA therapeutics in clinical trials
JC Burnett, JJ Rossi, K Tiemann
Biotechnology journal 6 (9), 1130-1146, 2011
4932011
Nanoparticle-based delivery of RNAi therapeutics: progress and challenges
J Zhou, KT Shum, JC Burnett, JJ Rossi
Pharmaceuticals 6 (1), 85-107, 2013
1862013
Gene and cell therapy: therapeutic mechanisms and strategies
NS Templeton
Crc Press, 2008
1602008
Combinatorial latency reactivation for HIV-1 subtypes and variants
JC Burnett, K Lim, A Calafi, JJ Rossi, DV Schaffer, AP Arkin
Journal of virology 84 (12), 5958-5974, 2010
1202010
Current progress of RNA aptamer-based therapeutics
J Zhou, M Bobbin, JC Burnett, JJ Rossi
Frontiers in genetics 3, 234, 2012
1062012
Control of stochastic gene expression by host factors at the HIV promoter
JC Burnett, K Miller-Jensen, PS Shah, AP Arkin, DV Schaffer
PLoS Pathog 5 (1), e1000260, 2009
1062009
HIV promoter integration site primarily modulates transcriptional burst size rather than frequency
R Skupsky, JC Burnett, JE Foley, DV Schaffer, AP Arkin
PLoS Comput Biol 6 (9), e1000952, 2010
952010
Potent and targeted activation of latent HIV-1 using the CRISPR/dCas9 activator complex
SM Saayman, DC Lazar, TA Scott, JR Hart, M Takahashi, JC Burnett, ...
Molecular therapy 24 (3), 488-498, 2016
922016
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells
J Zhou, K Tiemann, P Chomchan, J Alluin, P Swiderski, J Burnett, ...
Nucleic acids research 41 (7), 4266-4283, 2013
622013
Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity
J Zhou, S Satheesan, H Li, MS Weinberg, KV Morris, JC Burnett, JJ Rossi
Chemistry & biology 22 (3), 379-390, 2015
542015
HIV evades RNA interference directed at TAR by an indirect compensatory mechanism
JN Leonard, PS Shah, JC Burnett, DV Schaffer
Cell host & microbe 4 (5), 484-494, 2008
532008
RNA interference approaches for treatment of HIV-1 infection
ML Bobbin, JC Burnett, JJ Rossi
Genome medicine 7 (1), 50, 2015
492015
Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants
NM Snead, X Wu, A Li, Q Cui, K Sakurai, JC Burnett, JJ Rossi
Nucleic acids research 41 (12), 6209-6221, 2013
472013
Creating genetic resistance to HIV
JC Burnett, JA Zaia, JJ Rossi
Current opinion in immunology 24 (5), 625-632, 2012
462012
Improvements and limitations of humanized mouse models for HIV research: NIH/NIAID “meet the experts” 2015 workshop summary
R Akkina, A Allam, AB Balazs, JN Blankson, JC Burnett, S Casares, ...
AIDS research and human retroviruses 32 (2), 109-119, 2016
422016
Regulation of host gene expression by HIV-1 TAR microRNAs
DL Ouellet, J Vigneault-Edwards, K Létourneau, LA Gobeil, I Plante, ...
Retrovirology 10 (1), 1-15, 2013
412013
High throughput sequencing analysis of RNA libraries reveals the influences of initial library and PCR methods on SELEX efficiency
M Takahashi, X Wu, M Ho, P Chomchan, JJ Rossi, JC Burnett, J Zhou
Scientific reports 6 (1), 1-14, 2016
382016
The role of antisense long noncoding RNA in small RNA-triggered gene activation
X Zhang, H Li, JC Burnett, JJ Rossi
Rna 20 (12), 1916-1928, 2014
332014
The system can't perform the operation now. Try again later.
Articles 1–20